Related Experiment Video For glucose metabolism
Updated: Jan 10, 2026
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Increased Serum Levels of LDHA and TPI1 in Patients With Polycystic Ovary Syndrome
Wenjing Wang1, Tizhen Yan1, Manna Sun2
1Prenatal Diagnostic Center, Dongguan Maternal and Children Health Hospital, Dongguan, Guangdong, People's Republic of China.
Background:
Polycystic ovary syndrome (PCOS) is a metabolic disorder affecting women of reproductive age, and its etiology remains unclear. Therefore, it is crucial to identify biomarkers of the metabolic disturbances in PCOS.
Methods:
A total of eight clinical PCOS samples and control group samples were analyzed using data-independent acquisition (DIA) proteomics. Clinical data were used to identify protein biomarkers, and enzyme-linked immunosorbent assay (ELISA) validation was performed on 27 PCOS and 23 control samples.
Results:
In the PCOS samples, a total of 114 differentially expressed proteins were identified, with 37 upregulated and 77 downregulated. Further biofunctional analysis using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways revealed two differentially expressed proteins, lactate dehydrogenase A (LDHA) and triosephosphate isomerase 1 (TPI1), both of which were significantly upregulated in clinical PCOS samples. LDHA and TPI1 are involved in the glycolysis/gluconeogenesis metabolic pathway. Finally, ELISA was used to validate the high expression of LDHA and TPI1 in PCOS patients.
Conclusion:
DIA proteomics effectively identifies PCOS biomarkers. LDHA and TPI1 may serve as diagnostic biomarkers and could exert effects through glycolytic pathways.
Related Concept Videos
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion